ABSTRACT The activity of fish acid proteases is strongly dependent on the pH, and many basic and applied works had focused on researching the pH-profile of digestive proteases using different buffered media. Nevertheless, enzymatic activity is also known to be affected by the ionic strength (IS) of the medium. The present work is aimed at researching the combined effects of pH (2.5, 3.0, 3.5, 3.75 and 4.0) and IS (50, 100 and 200 mM) on the protease activity of gastric extracts of juvenile Coho salmon Oncorhynchus kisutch. It is concluded that the activity of Coho salmon gastric proteases is maximal at pH 2.5-3.0, drops towards pH 4.0 irrespective of ionic strength, and they showed a lower activity at IS 50 mM in comparison to IS 100 or 200 mM. The present results point out to the convenience of considering the effect of ionic strength when measuring the activity of fish gastric proteases.

Gene therapy is a promising tool for the treatment of ocular diseases. Nevertheless, there are some import limitations, especially related to the ocular route and the characteristics of nucleic acids that must be overcome to ensure the success of the therapy. In this context, nanotechnology-based carriers such as nanoemulsions, nanoparticles, dendrimers and liposomes have risen as a promising vehicle for the protection of genetic material for vectoring the target cells. The success of such approach is closely related to the judicious selection of the biomaterial, where chemical structure and intermolecular interactions play a major role. So, this manuscript reviews some of the most important biomaterials, lipid and polymeric origin, employed in the manufacture of nanotechnologic carriers for ocular gene therapy involving interfering RNA (siRNA), antisense oligonucleotide (AS-ON) and plasmid DNA (pDNA).

AbstractDepending on the method of extraction, plant extracts can contain an enormous variety of active molecules, such as phenolic compounds, essential oils, alkaloids, among others. In many cases, from a pharmacological point of view, it is interesting to work with crude extract or fractions instead of a single isolated compound. This could be due to multi-targeting effect of the extract, lack of knowledge of the active compounds, synergistic effect of the extract compounds, among others. In any case, in order to achieve a final product some issues must be overcome, including poor stability, solvent toxicity, and low solubility of the bioactive compound. Recently many nanotechnology-based strategies have been proposed as an alternative to solve these problems, especially liposomes, nanoemulsions and nanoparticles. In this sense, the present work aims to review the main nanotechnological approaches used for association of different plant extracts and the main achievements from using these technologies.

FUNDAMENTO: A insuficiência cardíaca pode apresentar disfunção assintomática à descompensação, com limitações e diminuição da capacidade produtiva. A pressão positiva contínua nas vias aéreas (CPAP) é um meio não farmacológico de redução da pós-carga. OBJETIVO: Analisar os efeitos da CPAP (10 cmH2O), por 30 dias, em paciente com insuficiência cardíaca crônica. MÉTODOS: Avaliamos 10 pacientes, com diversas etiologias, idade média de 54 ± 14 anos, sexo (masc.= 6 e fem.= 4), com IMC de 21 ± 0,04 kg/m². A terapia foi ofertada por 60 min., 5 vezes por semana, durante 1 mês, no período diurno. Foram analisados ecocardiograma e ergoespirometria, antes e após 30 dias de terapia. RESULTADOS: Apresentou aumento de 19,59% na fração de ejeção do ventrículo esquerdo (FEVE): 23.9 ± 8.91 vs 27.65 ± 9.56%; p = 0,045. Na ergoespirometria, o tempo de exercício (Tex) apresentou aumento significante de 547 ± 151,319 vs 700 ± 293,990 seg., p = 0,02, o consumo de oxigênio (VO2) foi de 9,59 ± 6,1 vs 4,51 ± 2,67 ml.kg-1.min.-1 , p = 0,01, enquanto a produção de dióxido de carbono (VCO2) de repouso (9,85 ± 4,38 vs 6,44 ± 2,88 ml.kg-1.min.-1 , p = 0,03) apresentou diminuição. CONCLUSÃO: A CPAP provocou aumento na fração de ejeção do ventrículo esquerdo e no tempo de exercício, diminuiu o consumo de oxigênio e a produção de dióxido de carbono no repouso.

BACKGROUND: Heart failure can present with asymptomatic dysfunction at decompensation, with limitations and decrease in the productive capacity. The Continuous Positive Airway Pressure (CPAP) is a non-pharmacological means to decrease afterload. OBJECTIVE: To analyze the effects of CPAP (10 cmH2O), for 30 days in patients with chronic heart failure. METHODS: We assessed 10 patients with heart failure (6 males, 4 females) of several etiologies, with a mean age of 54 ± 14 years, with a BMI of 21 ± 0.04 kg/m². The therapy was applied for 60 min., 5 times a week for 30 days, during the daytime. The echocardiogram and the ergospirometry were analyzed, before and 30 days after the therapy. RESULTS: There was a 19.59% increase in the left ventricular ejection fraction (LVEF): 23.9 ± 8.91 vs 27.65 ± 9.56%; p = 0.045. At the ergospirometry, the exercise time (ET) showed a significant increase from 547 ± 151.319 vs 700 ± 293.990 sec., p = 0.02; oxygen consumption (VO2) was 9.59 ± 6.1 vs 4.51 ± 2.67 ml.kg-1.min.-1, p = 0.01, whereas the carbon dioxide production (VCO2) at rest (9.85 ± 4.38 vs 6.44 ± 2.88 ml.kg-1.min.-1, p = 0.03) decreased. CONCLUSION: The CPAP resulted in an increase in the LVEF and ET, decreased the oxygen consumption and the carbon dioxide production at rest.

FUNDAMENTO: La insuficiencia cardíaca puede presentar disfunción asintomática a la descompensación, con limitaciones y disminución de la capacidad productiva. La presión positiva continua en las vías aéreas (CPAP) es un medio no farmacológico de reducción de la post-carga. OBJETIVO: Analizar los efectos de la CPAP (10 cmH2O), por 30 días, en paciente con insuficiencia cardíaca crónica. MÉTODOS: Evaluamos 10 pacientes, con diversas etiologías, edad media de 54 ± 14 años, sexo (masc.= 6 y fem.= 4), con IMC de 21 ± 0,04 kg/m². La terapia fue ofertada por 60 min., 5 veces por semana, durante 1 mes, en el período diurno. Fueron analizados ecocardiograma y ergoespirometría, antes y después de 30 días de terapia. RESULTADOS: Presentó aumento de 19,59% en la fracción de eyección del ventrículo izquierdo (FEVE): 23.9 ± 8.91 vs 27.65 ± 9.56%; p = 0,045. En la ergoespirometría, el tiempo de ejercicio (Tex) presentó aumento significativo de 547 ± 151,319 vs 700 ± 293,990 seg., p = 0,02, el consumo de oxígeno (VO2) fue de 9,59 ± 6,1 vs 4,51 ± 2,67 ml.kg-1.min.-1, p = 0,01, en cuanto a la producción de dióxido de carbono (VCO2) de reposo (9,85 ± 4,38 vs 6,44 ± 2,88 ml.kg-1.min.-1, p = 0,03) presentó disminución. CONCLUSIÓN: La CPAP provocó aumento en la fracción de eyección del ventrículo izquierdo y en el tiempo de ejercicio, disminuyó el consumo de oxígeno y la producción de dióxido de carbono en reposo.

This paper describes the adsorption of an oligothymidylate (pdT16) on nanoemulsions obtained by spontaneous emulsification procedures. Formulations were composed by medium chain triglycerides, egg lecithin, glycerol, water (NE) and stearylamine (NE SA). After optimization of operating conditions, the mean droplet size was smaller than 255 nm. Adsorption isotherms showed a higher amount of pdT16 adsorbed on cationic NE SA (60 mg/g) compared to NE (20 mg/g). pdT16 adsorption was also evidenced by the inversion of the zeta-potential of NE SA (from +50 to -30 mV) and the morphology of oil droplets examined through transmission electron microscopy. The overall results showed the role of electrostatic interactions on the adsorption of pdT16 on the oil/water interface of nanoemulsions.